<DOC>
<DOCNO>EP-1156854</DOCNO> 
<TEXT>
<INVENTION-TITLE>
USE OF CERAMIDES FOR THE TREATMENT OF CYSTIC FIBROSIS
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3100	A61K3100	A61K3116	A61K3116	A61P1100	A61P1100	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61P	A61P	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61P11	A61P11	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to the use of ceramides and/or substances which contain ceramides as a building block. Said ceramides and substances are used for the treatment of cystic fibrosis. The ceramides are especially C2 and/or C6 ceramides. The invention also relates to the use of the above-mentioned substances for the treatment of diseases which are linked to a disturbed regulation of transport processes at membranes.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
LANG FLORIAN
</APPLICANT-NAME>
<APPLICANT-NAME>
LANG, FLORIAN
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
GULBINS ERICH
</INVENTOR-NAME>
<INVENTOR-NAME>
LANG FLORIAN
</INVENTOR-NAME>
<INVENTOR-NAME>
LEPPLE-WIENHUES
</INVENTOR-NAME>
<INVENTOR-NAME>
GULBINS, ERICH
</INVENTOR-NAME>
<INVENTOR-NAME>
LANG, FLORIAN
</INVENTOR-NAME>
<INVENTOR-NAME>
LEPPLE-WIENHUES
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
